TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2025 | ₹3,364 Cr |
Mar2024 | ₹2,824 Cr |
Mar2023 | ₹2,431 Cr |
Mar2022 | ₹2,480 Cr |
Mar2021 | ₹2,170 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹3,364 Cr | 19.11 | |
Mar2024 | ₹2,824 Cr | 16.15 | |
Mar2023 | ₹2,431 Cr | -1.97 | |
Mar2022 | ₹2,480 Cr | 14.27 | |
Mar2021 | ₹2,170 Cr | - |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹119,695.5 Cr | 0.3% | -1.6% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,893.0 Cr | 1% | 4.8% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹171,976.0 Cr | 11.2% | 7.4% | 10.5% | Stock Analytics | |
CIPLA | ₹126,137.0 Cr | 3.2% | -0.1% | -7.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 1.3% | -3% | -6.5% | Stock Analytics | |
MANKIND PHARMA | ₹101,491.0 Cr | 0.3% | -5.8% | -4.8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 0.3% |
-1.6% |
0.8% |
SENSEX | 1.6% |
1.7% |
1.8% |
You may also like the below Video Courses